Recently, we have shown that Type 2 transglutaminase (TG2) negatively regulates IRF3/IFNI axis by controlling IRF3 activation, resulting in a reduction of IFNβ expression, thus regulating cellular response to bacterial infections [12, 13]. The gene discussed is IRF3; the disease is bacterial infectious disease.